Muscular Dystrophy: Inhibition of Degeneration in Vivo with Protease Inhibitors
- 7 April 1978
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 200 (4337) , 50-51
- https://doi.org/10.1126/science.635570
Abstract
The protease inhibitors leupeptin and pepstatin were used in vivo in genetically dystrophic chickens to determine their effects on the histological and biochemical changes observed in this disease. These compounds appear to delay the degeneration of muscle tissue which is characteristic of this disorder and thus may have potential therapeutic value in the treatment of muscular dystrophy.This publication has 13 references indexed in Scilit:
- Intracellular calcium accumulation in Duchenne dystrophy and other myopathiesNeurology, 1978
- Avian Muscular Dystrophy: Functional and Biochemical Improvement with DiphenylhydantoinScience, 1977
- Postponement of symptoms of hereditary muscular dystrophy in chickens by 5-hydroxytryptamine antagonistsNature, 1976
- Delayed degeneration of dystrophic and normal muscle cell cultures treated with pepstatin, leupeptin, and antipainExperimental Neurology, 1976
- Beneficial effects of penicillamine treatment on hereditary avian muscular dystrophy.Journal of Clinical Investigation, 1975
- Ca2+-SPECIFIC REMOVAL OF Z LINES FROM RABBIT SKELETAL MUSCLEThe Journal of cell biology, 1972
- Cathepsin Activity in Normal and Dystrophic Human MuscleEnzymologia Biologica Et Clinica, 1968
- Increased lysosomal enzymes in genetic muscular dystrophyArchives of Biochemistry and Biophysics, 1962
- Enzyme Studies in Muscular Dystrophy. III. In Hereditary Muscular Dystrophy in Mice.Experimental Biology and Medicine, 1958
- A spectrophotometric method for the determination of creative phosphokinase and myokinaseBiochemical Journal, 1955